# OnCo record gadoteridol (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/gadoteridol/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "gadoteridol" ;
  schema:name "Gadoteridol"@en ;
  schema:alternateName "gadoteridol"@en, "ProHance"@en, "ProHance" ;
  schema:description "An MRI dye given into a vein for scans of the brain, spine, and head and neck."@en ;
  schema:url <https://onco.cc/drugs/gadoteridol/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020131>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=778aee03-7d4c-481a-be8a-a75db0702f5a>, <https://atcddd.fhi.no/atc_ddd_index/?code=V08CA&showdescription=no> ;
  onco:status "approved" ;
  onco:tag "contrast-agents-gaps-2026-11", "diagnostic" ;
  onco:modality "Gadolinium-based contrast agent for MRI of the brain, spine and head and neck (intravenous)" ;
  onco:approval "US 1992: MRI of the brain, spine and associated tissues; MRI of the head and neck in adults" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:technologies <https://onco.cc/technologies/gadolinium-based-contrast-agents/>, <https://onco.cc/technologies/mri/> ;
  onco:companies <https://onco.cc/companies/bracco/> .